Terranueva Corporation

L’ASSOMPTION, Quebec, April 14, 2022 -- Terranueva Corporation (CSE: TEQ) ("Terranueva") is pleased to announce the results of its annual and special meeting of shareholders held on April 14, 2022. The shareholders approved, by a majority of votes, a resolution to elect the following directors: Sylvain Aird, Marc-André Aubé, Marianne Fort... Read More...

L’ASSOMPTION, Québec, Dec. 20, 2021 -- Terranueva Corporation (CSE: TEQ) ("Terranueva" or the "Corporation") is pleased to announce that its subsidiary Terranueva Pharma Corporation has been granted an amendment to its cannabis production and processing license now allowing it to sell dried cannabis to the public through authorized provin... Read More...

MONTREAL, April 27, 2021 -- The Board of Directors of Terranueva Corporation (CSE: TEQ) ("Terranueva") is pleased to announce the appointment of Jean-Luc Landry as Executive Chairman of the Board of Directors and Chief Executive Officer, Gérard Landry as President and Chief Operating Officer and Director and Sylvain Tremblay as Director. ... Read More...

L’ASSOMPTION, Quebec, April 07, 2021 -- Terranueva Corporation (CSE : TEQ) (the “Corporation” or “Terranueva”), one of the 6 companies in Québec holding a licence from Health Canada to develop cannabis products for medical and recreational purposes, is pleased to announce that Canada Economic Development (“CED”) has granted the Corporatio... Read More...

MONTREAL, Nov. 02, 2020 -- Terranueva Corporation (CSE: TEQ) (“Terranueva” or the “Company”). The Board of Directors of Terranueva announced today a new organizational structure. Mr. Peter Polatos is appointed as interim President and Chief Executive Officer for the entire organization and also becomes a director of the Company."I am deli... Read More...

STOCK MARKET SYMBOL: TEQ L'ASSOMPTION, QC, Oct. 5, 2020 /CNW Telbec/ - Terranueva Corporation (CSE: TEQ) ("Terranueva"), one of six Quebec companies holding a license from Health Canada to develop cannabis-based medicinal products, is pleased to announce that the CED has granted a $500,000 repayable contribution to the Company in support ... Read More...

L’ASSOMPTION, Quebec, Sept. 24, 2020 -- Corporation Terranueva (CSE : TEQ) ) (the “Corporation” or “Terranueva”), one of the 6 companies in Québec holding a licence from Health Canada to develop cannabis products for medical and recreational purposes, is pleased to announce that Economic Development Canada (“EDC”) has granted a loan of $5... Read More...

L’ASSOMPTION, Québec, Sept. 04, 2020 -- Corporation Terranueva (CSE : TEQ) (the “Corporation” or “Terranueva”) announces that it has filed a licence amendment request with Health Canada to obtain the authorization to sell finished products in the retail cannabis market. Terranueva is now awaiting comments from Health Canada.Terranueva has... Read More...

L’ASSOMPTION, Quebec, July 15, 2020 -- CORPORATION TERRANUEVA (CSE : TEQ) (the “Corporation” or “Terranueva”) and Laboratoire LSL Inc. ("Laboratoire LSL") announce that the parties have terminated their contractual relationship for the acquisition of the securities of Laboratoire LSL announced by press release on March 27, 2020.The Corpor... Read More...

L’ASSOMPTION, Québec, May 29, 2020 -- Terranueva Corporation (CSE : TEQ) (the “Corporation” or “Terranueva”) announces its intention to amend the term and exercise price of the 2,310,000 Series A warrants issued as part of a private placement which closed on December 14, 2018 (the “Warrants”). Under the current terms, each Warrant can be ... Read More...

L’ASSOMPTION, Quebec, March 27, 2020 -- CORPORATION TERRANUEVA (CSE : TEQ) (the “Corporation” or “Terranueva”) announces that it has reached a preliminary agreement, which became effective on March 26, 2020 following the consent of the two main creditors of Terranueva, with the owners of the pharmaceutical company LSL Laboratory Inc. (“LS... Read More...

MONTREAL, Dec. 11, 2019 -- Corporation Terranueva (CSE: TEQ) ("Terranueva") announces the closing of a secured $2M revolving credit facility (the "Revolving Credit") with a lending institution. Under the terms of the Revolving Credit, the funds will be used to finance the activities of its subsidiary, Terranueva Pharma Corporation, to fin... Read More...

L’ASSOMPTION, Quebec, July 17, 2019 -- Corporation Terranueva (CSE:TEQ) ("Terranueva") is pleased to announce the completion of its first harvest in its certification, research and development unit ("CRDU")."We are very pleased with the first results, the yield is higher than we expected, which allows us to confirm that our growing method... Read More...

L'ASSOMPTION, Quebec, April 16, 2019 -- Terranueva Corporation (CSE:TEQ) ("Terranueva" or the "Corporation") is pleased to announce that it is joining the Quebec Cannabis Industry Association (QCIA) as Founding Member. By taking an active role on the QCIA Board of Directors, Terranueva shows it is fully committed to a strong cannabis indu... Read More...

MONTRÉAL, April 15, 2019 -- Terranueva Corporation (CSE:TEQ) ("Terranueva" or the "Corporation") is pleased to announce that, following the issuance of culture, transformation and sale (medical) licenses issued by Health Canada on February 22, the Company pursued its development plan by securing contingent options to purchase over 280,000... Read More...

MONTRÉAL, Feb. 19, 2019 -- TERRANUEVA CORPORATION (“Terranueva” or the “Company”) is pleased to announce that it has completed a private placement for an aggregate amount of $366,666 in common shares at a price of $0.50 per share, representing an aggregate of 733 332 shares of the capital stock of Terranueva. This private placement comes ... Read More...